|
|
Volumn 53, Issue 3, 1997, Pages 453-482
|
|
Epirubicin. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of breast cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DOXORUBICIN;
EPIRUBICIN;
FLUOROURACIL;
GRANULOCYTE COLONY STIMULATING FACTOR;
HEMOPOIETIC GROWTH FACTOR;
IFOSFAMIDE;
LONIDAMINE;
METHOTREXATE;
MITOXANTRONE;
NAVELBINE;
PACLITAXEL;
QUINIDINE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
TAMOXIFEN;
VERAPAMIL;
ADVANCED CANCER;
ALOPECIA;
ARTICLE;
BLOOD TOXICITY;
BONE MARROW SUPPRESSION;
BREAST CANCER;
CANCER SURVIVAL;
CARDIOTOXICITY;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
DNA STRAND BREAKAGE;
DOSE RESPONSE;
DRUG CLEARANCE;
DRUG ELIMINATION;
EARLY CANCER;
FEVER;
HEMATOPOIETIC STEM CELL;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKEMIA;
META ANALYSIS;
METASTASIS;
MUCOSA INFLAMMATION;
NAUSEA;
NONHUMAN;
PHLEBITIS;
SKIN MANIFESTATION;
VOMITING;
|
|
EID: 0030889489
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-199753030-00008 Document Type: Article |
|
Times cited : (109)
|
|
References (146)
|
